Effect of epigenetic treatment on SST <sub>2</sub> expression in neuroendocrine tumour patients-Reference-Cited by-同舟云学术

Effect of epigenetic treatment on SST ₂ expression in neuroendocrine tumour patients

Published:2022-07 Issue:7 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Refardt Julie¹²^ORCID,Klomp Maria J.¹³,van Koetsveld Peter M.¹,Dogan Fadime¹,Konijnenberg Mark³^ORCID,Brabander Tessa³,Feelders Richard A.¹,de Herder Wouter W.¹^ORCID,Hofland Leo J.¹,Hofland Johannes¹

Affiliation:

1. ENETS Center of Excellence, Department of Internal Medicine, Section of Endocrinology Erasmus Medical Center Rotterdam The Netherlands

2. ENETS Center of Excellence, Department of Endocrinology University Hospital Basel Basel Switzerland

3. ENETS Center of Excellence, Department of Radiology & Nuclear Medicine Erasmus Medical Center Rotterdam The Netherlands

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.957

Reference10 articles.

1. Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

2. Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells

3. Upregulation of Key Molecules for Targeted Imaging and Therapy

4. Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications;Current Problems in Cancer;2024-10

2. Structure and Function of Somatostatin and Its Receptors in Endocrinology;Endocrine Reviews;2024-08-08

3. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments;Theranostics;2024

4. Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice;Life Sciences;2023-12

5. Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors;Frontiers in Endocrinology;2023-05-08